Devonian Health Group Inc.
DVHGF
$7.00
-$3.65-34.27%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.18M | 7.23M | 13.08M | 16.81M | 23.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.18M | 7.23M | 13.08M | 16.81M | 23.29M |
| Cost of Revenue | 700.50K | 4.00M | 8.04M | 10.70M | 14.85M |
| Gross Profit | 1.48M | 3.23M | 5.04M | 6.11M | 8.44M |
| SG&A Expenses | 6.26M | 6.38M | 4.85M | 5.15M | 6.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 94.70K | 93.40K | 91.50K | 90.90K | 89.60K |
| Total Operating Expenses | 6.70M | 10.36M | 14.38M | 17.37M | 22.49M |
| Operating Income | -4.52M | -3.13M | -1.30M | -568.80K | 795.20K |
| Income Before Tax | -4.47M | -6.44M | -4.64M | -3.96M | -2.71M |
| Income Tax Expenses | -9.20K | -9.20K | 298.30K | 298.30K | 728.10K |
| Earnings from Continuing Operations | -4.46 | -6.43 | -4.94 | -4.26 | -3.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.46M | -6.43M | -4.94M | -4.26M | -3.44M |
| EBIT | -4.52M | -3.13M | -1.30M | -568.80K | 795.20K |
| EBITDA | -4.44M | -2.98M | -1.12M | -352.50K | 1.04M |
| EPS Basic | -2.22 | -3.08 | -1.95 | -1.72 | -1.39 |
| Normalized Basic EPS | -1.39 | -1.07 | -0.28 | -0.14 | 0.18 |
| EPS Diluted | -2.22 | -3.08 | -1.95 | -1.72 | -1.39 |
| Normalized Diluted EPS | -1.39 | -1.07 | -0.28 | -0.14 | 0.18 |
| Average Basic Shares Outstanding | 13.53M | 13.23M | 10.17M | 9.88M | 9.88M |
| Average Diluted Shares Outstanding | 13.53M | 13.23M | 10.17M | 9.88M | 9.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |